Reducing drug dosage, and hearing loss in TB patients without reducing efficacy

Aminoglycosides, recommended by the World Health Organization to treat multidrug resistant tuberculosis, cause hearing loss and kidney damage in a dose dependent manner. …read more

Via:: Medical News Today

      

Speak Your Mind

*